MedPath

Optimization of the treatment of Polycystic ovary syndrome with kidney deficiency and phlegm dampness

Not Applicable
Conditions
polycystic ovarian syndrome
Registration Number
ITMCTR2000003644
Lead Sponsor
The First Affiliated Hospital of Naval Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) At the same time, it conforms to the diagnostic criteria of PCOS in Western medicine and the diagnostic criteria of deficiency of kidney and phlegm-dampness in TCM;
(2) those who have not taken medication or have taken medication but have stopped medication for more than 3 months, and those who have not taken diet and exercise therapy;
(3) Volunteer to participate in this clinical study and sign the relevant informed consent.

Exclusion Criteria

(1) caused by other reasons and PCOS similar clinical sign and/or endocrine diseases, such as reproductive organs implement qualitative sex pathological change, Cushing's syndrome, theca cell hyperplasia with shaofu zhuyu tang, adrenal cortex hyperplasia, 21 hydroxylase deficiency, the ovaries or adrenal tumors, hyperprolactinemia and abnormal thyroid function, primary diabetes and other metabolic disorder diseases etc.
(2) Patients with serious primary diseases such as heart, liver, kidney and hematopoietic system, as well as psychosis;
(3) Allergic constitution, allergy to known drugs in this prescription or cause an unpleasant reaction;
(4) Incomplete data or inability to judge the efficacy and other factors affecting the efficacy or safety evaluation.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ovulation rate;
Secondary Outcome Measures
NameTimeMethod
clinical symptoms;TCM symptom;Laboratory tests;
© Copyright 2025. All Rights Reserved by MedPath